340 related articles for article (PubMed ID: 25976060)
21. The 5α-reductase inhibitor Dutasteride but not Finasteride protects dopamine neurons in the MPTP mouse model of Parkinson's disease.
Litim N; Bourque M; Al Sweidi S; Morissette M; Di Paolo T
Neuropharmacology; 2015 Oct; 97():86-94. PubMed ID: 26006269
[TBL] [Abstract][Full Text] [Related]
22. Admixing of MPTP-Resistant and Susceptible Mice Strains Augments Nigrostriatal Neuronal Correlates to Resist MPTP-Induced Neurodegeneration.
Vidyadhara DJ; Yarreiphang H; Raju TR; Alladi PA
Mol Neurobiol; 2017 Oct; 54(8):6148-6162. PubMed ID: 27704331
[TBL] [Abstract][Full Text] [Related]
23. Endurance Exercise Mediates Neuroprotection Against MPTP-mediated Parkinson's Disease via Enhanced Neurogenesis, Antioxidant Capacity, and Autophagy.
Jang Y; Kwon I; Song W; Cosio-Lima LM; Lee Y
Neuroscience; 2018 May; 379():292-301. PubMed ID: 29559387
[TBL] [Abstract][Full Text] [Related]
24. Gintonin Mitigates MPTP-Induced Loss of Nigrostriatal Dopaminergic Neurons and Accumulation of α-Synuclein via the Nrf2/HO-1 Pathway.
Jo MG; Ikram M; Jo MH; Yoo L; Chung KC; Nah SY; Hwang H; Rhim H; Kim MO
Mol Neurobiol; 2019 Jan; 56(1):39-55. PubMed ID: 29675576
[TBL] [Abstract][Full Text] [Related]
25. TRPM2 Promotes Neurotoxin MPP
Sun Y; Sukumaran P; Selvaraj S; Cilz NI; Schaar A; Lei S; Singh BB
Mol Neurobiol; 2018 Jan; 55(1):409-420. PubMed ID: 27957685
[TBL] [Abstract][Full Text] [Related]
26. Knockdown of long non-coding RNA AL049437 mitigates MPP+ -induced neuronal injury in SH-SY5Y cells via the microRNA-205-5p/MAPK1 axis.
Zhang L; Wang J; Liu Q; Xiao Z; Dai Q
Neurotoxicology; 2020 May; 78():29-35. PubMed ID: 32057949
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-124 Enhances Dopamine Receptor Expression and Neuronal Proliferation in Mouse Models of Parkinson's Disease via the Hedgehog Signaling Pathway by Targeting EDN2.
Wang J; Wang W; Zhai H
Neuroimmunomodulation; 2019; 26(4):174-187. PubMed ID: 31454817
[TBL] [Abstract][Full Text] [Related]
28. Kir6.1/K-ATP channel on astrocytes protects against dopaminergic neurodegeneration in the MPTP mouse model of Parkinson's disease via promoting mitophagy.
Hu ZL; Sun T; Lu M; Ding JH; Du RH; Hu G
Brain Behav Immun; 2019 Oct; 81():509-522. PubMed ID: 31288070
[TBL] [Abstract][Full Text] [Related]
29. LncRNA H19 Attenuates Apoptosis in MPTP-Induced Parkinson's Disease Through Regulating miR-585-3p/PIK3R3.
Zhang Y; Xia Q; Lin J
Neurochem Res; 2020 Jul; 45(7):1700-1710. PubMed ID: 32356199
[TBL] [Abstract][Full Text] [Related]
30. miR-132-5p regulates apoptosis and autophagy in MPTP model of Parkinson's disease by targeting ULK1.
Zhao J; Yang M; Li Q; Pei X; Zhu X
Neuroreport; 2020 Sep; 31(13):959-965. PubMed ID: 32658123
[TBL] [Abstract][Full Text] [Related]
31. Prevention of MPTP (N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) dopaminergic neurotoxicity in mice by chronic lithium: involvements of Bcl-2 and Bax.
Youdim MB; Arraf Z
Neuropharmacology; 2004 Jun; 46(8):1130-40. PubMed ID: 15111020
[TBL] [Abstract][Full Text] [Related]
32. Deletion of autophagy-related gene 7 in dopaminergic neurons prevents their loss induced by MPTP.
Niu XY; Huang HJ; Zhang JB; Zhang C; Chen WG; Sun CY; Ding YQ; Liao M
Neuroscience; 2016 Dec; 339():22-31. PubMed ID: 27693472
[TBL] [Abstract][Full Text] [Related]
33. Silencing RNF13 Alleviates Parkinson's Disease - Like Problems in Mouse Models by Regulating the Endoplasmic Reticulum Stress-Mediated IRE1α-TRAF2-ASK1-JNK Pathway.
Ji M; Niu S; Guo J; Mi H; Jiang P
J Mol Neurosci; 2020 Dec; 70(12):1977-1986. PubMed ID: 32617872
[TBL] [Abstract][Full Text] [Related]
34. MiR-29c protects against inflammation and apoptosis in Parkinson's disease model in vivo and in vitro by targeting SP1.
Wang R; Yang Y; Wang H; He Y; Li C
Clin Exp Pharmacol Physiol; 2020 Mar; 47(3):372-382. PubMed ID: 31732967
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic activation of autophagy by combined treatment with rapamycin and trehalose in a mouse MPTP-induced model of Parkinson's disease.
Pupyshev AB; Tikhonova MA; Akopyan AA; Tenditnik MV; Dubrovina NI; Korolenko TA
Pharmacol Biochem Behav; 2019 Feb; 177():1-11. PubMed ID: 30582934
[TBL] [Abstract][Full Text] [Related]
36. Secalonic acid A protects dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP⁺)-induced cell death via the mitochondrial apoptotic pathway.
Zhai A; Zhu X; Wang X; Chen R; Wang H
Eur J Pharmacol; 2013 Aug; 713(1-3):58-67. PubMed ID: 23665112
[TBL] [Abstract][Full Text] [Related]
37. Altered dopamine metabolism and increased vulnerability to MPTP in mice with partial deficiency of mitochondrial complex I in dopamine neurons.
Sterky FH; Hoffman AF; Milenkovic D; Bao B; Paganelli A; Edgar D; Wibom R; Lupica CR; Olson L; Larsson NG
Hum Mol Genet; 2012 Mar; 21(5):1078-89. PubMed ID: 22090423
[TBL] [Abstract][Full Text] [Related]
38. Impaired CBS-H
Yuan YQ; Wang YL; Yuan BS; Yuan X; Hou XO; Bian JS; Liu CF; Hu LF
Brain Behav Immun; 2018 Jan; 67():77-90. PubMed ID: 28774789
[TBL] [Abstract][Full Text] [Related]
39. (E)-2-methoxy-4-(3-(4-methoxyphenyl) prop-1-en-1-yl) Phenol Ameliorates MPTP-Induced Dopaminergic Neurodegeneration by Inhibiting the STAT3 Pathway.
Choi JY; Yun J; Hwang CJ; Lee HP; Kim HD; Chun H; Park PH; Choi DY; Han SB; Hong JT
Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31146332
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-216a inhibits neuronal apoptosis in a cellular Parkinson's disease model by targeting Bax.
Yang X; Zhang M; Wei M; Wang A; Deng Y; Cao H
Metab Brain Dis; 2020 Apr; 35(4):627-635. PubMed ID: 32140823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]